Market Research Logo

The US Rosacea Market: Size, Trends & Forecasts (20018-2022)

The US Rosacea Market: Size, Trends & Forecasts (20018-2022)

Scope of the Report

The report titled “The US Rosacea Market: Size, Trends & Forecasts (20018-2022)”, provides a detailed analysis of the US rosacea market with market sizing and growth pattern. The analysis includes rosacea market in terms of value, number of patients; number of patients seeking treatment and market share by segments. It also provides analysis of the US dermatology drugs market in terms of value and market share by segments.

Furthermore, the report also assesses the key opportunities available in the market and summarizes the dynamic forces that are and will be accountable for growth of the industry. Growth of the US rosacea market has also been forecasted for the period 2018-2022, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.

Foamix Pharmaceuticals Ltd., Bayer Group, Galderma and Valeant Pharmaceuticals International are some of the major players whose company profiling has been done in the report. This segment of the report summarizes business overview, financial overview and the business strategies adopted by respective companies.

Company Coverage

Foamix Pharmaceuticals Ltd.
Bayer Group
Galderma
Valeant Pharmaceuticals International

Executive Summary

Rosacea is a common chronic condition of the skin with a high prevalence rate among the US population. It is observed that it naturally begins at any time after the age of 30 and more and mostly affect the area of nose, cheeks and forehead. In some cases, rosacea may also occur on the neck, chest, scalp or ears. Rosacea symptoms and signs include facial flushing, fine red vascular lines, swollen, red eyelids and many more. The disease is more common in women and those who have fair skin. The cause of such skin condition is still unknown and cannot be cured. The only way to control rosacea is by minimizing its symptoms.

The US rosacea market has grown over the past few years and is anticipated to grow during the forecasted period also i.e. 2018-2022 at a high growth rate on the back of rising incidence rate of the disease among the US population.

The growth in the market will be driven by aging population, unhealthy eating habits and environmental factors, rising disposable income and entry of new drugs and treatments in the market. Yet the market growth is restrained by factors such as lack of awareness and knowledge and stringent government regulations for the approval of new drugs.


1. Executive Summary
2. Introduction
2.1 Overview of Rosacea
2.1.1 Symptoms of Rosacea
2.1.2 Causes of Rosacea
2.1.3 Types of Rosacea
Table 1: Types of Rosacea
3. Market Analysis
3.1 The US Dermatology Drugs Market Analysis
3.1.1 The US Dermatology Drugs Market by Value
Table 2: The US Dermatology Drugs Market by Value; 2014-2017 (US$ Billion)
Table 3: The US Dermatology Drugs Market by Value; 2018-2022E (US$ Billion)
3.1.2 The US Dermatology Drugs Market by Segments
Table 4: The US Dermatology Drugs Market by Segments; 2016
3.2 The US Rosacea Market Analysis
3.2.1 The US Rosacea Market by Value
Table 5: The US Rosacea Market by Value; 2016-2017 (US$ Billion)
Table 6: The US Rosacea Market by Value; 2018-2022E (US$ Billion)
3.2.2 The US Rosacea Market by Number of Patients
Table 7: The US Rosacea Market by Number of Patients; 2016-2017 (Million)
Table 8: The US Rosacea Market by Number of Patients; 2018-2022E (Million)
3.2.3 The US Rosacea Market by Number of Patients Seeking Treatment
Table 9: The US Rosacea Market by Number of Patients Seeking Treatment;
2017-2022 (Million)
3.2.4 The US Rosacea Market by Segments
Table 10: The US Rosacea Market by Segments; 2016
3.2.5 The US Rosacea Market Top Brands by Value
Table 11: The US Rosacea Market Top Brands by Value; 2016
3.2.6 The US Rosacea Market Top Brands by Volume
Table 12: The US Rosacea Market Top Brands by Volume; 2016
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Unhealthy Eating Habits and Environmental Factors
4.1.2 High Prevalence Rate of Rosacea
4.1.3 Aging Population
Table 13: Share of Old Age Population (65 years and Older) in the Total US Population; 1990-2020 (%)
4.1.4 Rising Disposable Personal Income
Table 14: The US Disposable Personal Income; 2013-2017 (US$ Trillion)
4.2 Challenges
4.2.1 Lack of Awareness
4.2.2 Stringent Government Regulations
4.3 Market Trends
4.3.1 Approval of New Drugs
5. Competitive Landscape
5.1 The US Rosacea Market by Players/Drugs
Table 15: The US Rosacea Market by Players/Drugs; 2016
5.2 The US Rosacea Drugs Competitive Landscape
Table 16: The US Rosacea Drugs Competitive Landscape
6. Company Profiles
6.1 Foamix Pharmaceuticals Ltd.
6.1.1 Business Overview
Table 17: Product Candidate Pipeline
Table 18: Finacea (FMX103) related Events (Completed and Anticipated)
6.1.2 Financial Overview
Table 19: Foamix Pharmaceuticals Ltd. Revenues; 2012-2016 (US$ Million)
6.1.3 Business Strategy
6.2 Bayer Group
6.2.1 Business Overview
6.2.2 Financial Overview
Table 20: Bayer Group Revenues; 2012-2016 (US$ Billion)
Table 21: Bayer Group Revenue by Segments; 2016
Table 22: Bayer Group Revenue by Geography; 2016
6.2.3 Business Strategy
6.3 Galderma
6.3.1 Business Overview
6.3.2 Financial Overview
6.4 Valeant Pharmaceuticals International
6.4.1 Business Overview
6.4.2 Financial Overview
Table 23: Valeant Pharmaceuticals Revenue; 2012-2016 (US$ Billion)
Table 24: Valeant Pharmaceuticals Revenue by Segments; 2016
6.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report